The Korea Herald

소아쌤

[STOCK WATCH] Genic falls 5%

By thinkpool

Published : Oct. 25, 2016 - 15:21

    • Link copied

 
 


Market Review
On Oct. 25, Genic (123330) declined 5.46% to 17,300 won (US$15.22). It had declined 17.62% through the past month. Standard deviation, the risk index for stock price, was 3.1% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of Genic was around the average of that of its peer group, but the investment return for 1 month was at an absolutely low level. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -5.6%. As high volatility and a bearish stock price trend, the return-on-risk was poor, compared with its peer group. However, the return-on-risk is much better than the industrial mean, -8.2, and thus the industrial comparison performance was good.

Comparing industry to the market, the KOSDAQ industry including Genic records lower volatility and earning rate than Chemicals. In other words, the industry was safer and the rate of decrease is smaller than that of the market.


Earning rate (%)
Close Competitors

Target price 30,000 won, has 73% disparate to increase compared with stock price.
Per analysts' expectations during the recent month, the average target price of Genic is 30,000 won. The stock price is 17,300 won as of yesterday, so there is 12,700 (73%) won disparate in order to be able to increase.



Earnings & Valuation
Genic(123330): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 12. 2016)
Revenue
 

Financial structure Overview
Compared with 4 close competitors with similar market capitalization within its industry, while Genic's P/E ratio, a price-paid ratio of annual net income, is relatively higher value, its P/B ratio, a financial ratio of a company's book value, records a proper value.

P/E ratio and P/B ratio
Close Compatitors ROE



Investor Group
Institutions and Foreigners sell, Individuals buy
While Institutions have been selling Genic during the past 11 trading days, foreigners have been buying during the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, foreigners have sold 23,088 shares and Institutions have sold 68,502 shares with a changing stance to selling from buying. However, during the same period, individuals have bought 91,590 shares with an increasing position.

Turnover Rate and Price Range both proper
Regarding the statistics for the past month on trade volume as the total outstanding shares, the daily turnover rate of Genic was 0.98%. And the daily volatility, the average range of rise and fall, during the same period is 4.27%.

The main shareholding group is Individuals
As per the inquiry for shareholding by investor group, the major investor group is Individuals with 80.22% from total outstanding shares. Institutions and foreigners each hold 11.16% and 8.61%. And as recent 5-day shareholding change by investor group, individuals is the major investor group with 76.91%. Institutions hold 18.02% and foreigners hold 5.06%.

Cumulated shareholdings per investor group (1Mo)  
* Other Investor groups, included as "other corporations", are considered as "Individuals".

By HeRo (hero@heraldcorp.com

This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.